Calcium antagonists in hypertension: From hemodynamics to outcomes

American Journal of Hypertension

Volumn 15, Issue 7 II, 2002, Pages

  Messerli, Franz H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Calcium antagonists; Dihydropyridines; Hypertension; Lercanidipine

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE; ISRADIPINE; LACIDIPINE; LERCANIDIPINE; MANIDIPINE; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT;

CONFERENCE PAPER; DRUG EFFICACY; EDEMA; GERIATRIC PATIENT; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; VASCULAR RESISTANCE; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; TREATMENT OUTCOME;

EID: 0036632607     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(02)02950-3     Document Type: Conference Paper

References (25)

1. Shanghai trial of nifedipine in the elderly (STONE)
2. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
3. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
4. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
5. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
6. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
7. Effect of verapamil on mortality major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAV-ITT II)
8. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients
9. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
10. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
11. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure
12. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
13. Evidence-based evaluation of calcium channel blockers for hypertension: Equality of mortality and cardiovascular risk relative to conventional therapy
14. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
15. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
16. Vasodilatory edema: A common side effect of antihypertensive therapy
17. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension
18. Vasodilatory edema: Synergistic effect of high-dose calcium antagonist/ACE inhibitor combination therapy
19. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists
20. Lercanidipine: Short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties
21. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues
22. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats
23. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements
24. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: A double-blind, randomized parallel-group study
25. Tolerability of long-term treatment with lercanidipine vs. amlodipine and lacidipine in elderly hypertensives